PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 13, 2019Blood Reviews103 citationsOpen Access

Extramedullary disease in multiple myeloma – controversies and future directions

View Full Paper
SŠSabina Ševčı́kováJMJiří MinaříkMŠMartin Štork

Key Points

Key points are not available for this paper at this time.

Abstract

Extramedullary disease of multiple myeloma (EM) remains a treatment challenge even in the era of new drugs. While many reports analyzing various aspects of EM have been published, mechanism of EM development has not been clarified yet. This review summarizes current knowledge about this clinical entity, including its history, diagnostics, imaging methods, incidence, prognosis, current treatment options, risk factors and known molecular mechanisms that might be involved in pathogenesis of EM.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ševčı́ková et al. (2019) studied this question.

synapsesocial.com/papers/6a0ceb70d09dbb66ef026485https://doi.org/10.1016/j.blre.2019.04.002
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients.2007 · 4 citations
  2. 2Extramedullary multiple myeloma escapes the effect of thalidomide.2004 · 135 citations
  3. 3MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis2008 · 576 citations
  4. 4Where are we now with the treatment of multiple myeloma?2017 · 12 citations
  5. 5Extramedullary lesions in multiple myeloma; review of literature and pathologic studies.1952 · 155 citations